Angirid Tablet

About Angirid 35 mg Tablet

Angirid 35 mg tablet is a medicine made by The ACME Laboratories Ltd. It is not meant to relieve an angina attack, to treat unstable angina as an initial treatment, or to treat myocardial infarction.

There are 13 brands of Trimetazidine Dihydrochloride listed in Bangladesh. The lowest listed price is Feelnor 20 mg Tablet at ৳ 3 per unit.

What is Angirid 35 mg Tablet?

Made by The ACME Laboratories Ltd., Angirid is a tablet whose active ingredient is Trimetazidine Dihydrochloride. Angirid does not treat angina attacks when they happen, and it is not a treatment for unstable angina or heart attack. It works by shifting the heart's energy production toward glucose, which uses oxygen more efficiently. The doctor decides the dose and course.

Uses of Angirid

It is not meant to relieve an angina attack, to treat unstable angina as an initial treatment, or to treat myocardial infarction. It is meant for people whose angina is not adequately controlled by first-line anti-anginal therapy, or who cannot tolerate those treatments. Angirid is not a curative treatment for angina attacks, not an initial treatment for unstable angina pectoris, and not a treatment for myocardial infarction. Your doctor will decide if it is suitable for you.

How to use Angirid

Angirid 35 mg is a tablet and is usually taken with meals. Swallow the tablet with water. Angirid is taken by mouth. Take Angirid 35 mg tablet exactly as your doctor prescribes. If you miss a dose or have questions about how to take it, ask your doctor or pharmacist. The doctor decides the dose, how often to take it and how long the course lasts.

Side effects of Angirid

Commonly reported ones include dizziness, headache, abdominal pain, diarrhoea, indigestion, nausea and vomiting. Some people may notice dizziness, headache, abdominal pain, diarrhoea, indigestion, nausea, vomiting, rash, itching, hives or weakness. Contact your doctor if you notice anything unusual after taking it. Tell your doctor if any side effect bothers you or does not go away.

Safety and precautions

It is also contraindicated in anyone hypersensitive to the active substance or to any of the excipients. Avoid it during pregnancy and breast-feeding. Tell the doctor about pregnancy, breastfeeding and all other conditions and medicines first. Keep out of reach of children.

Frequently asked questions

What is Angirid used for?

It is not meant to relieve an angina attack, to treat unstable angina as an initial treatment, or to treat myocardial infarction. It is meant for people whose angina is not adequately controlled by first-line anti-anginal therapy, or who cannot tolerate those treatments.

How is Angirid used?

Angirid 35 mg is a tablet and is usually taken with meals. Swallow the tablet with water.

What should I watch for while using Angirid?

Commonly reported ones include dizziness, headache, abdominal pain, diarrhoea, indigestion, nausea and vomiting. Some people may notice dizziness, headache, abdominal pain, diarrhoea, indigestion, nausea, vomiting, rash, itching, hives or weakness.

Is Angirid safe for everyone?

It is also contraindicated in anyone hypersensitive to the active substance or to any of the excipients. Avoid it during pregnancy and breast-feeding.

Indications

Trimetazidine Dihydrochloride is indicated in adults as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled by or intolerant to first-line antianginal therapies.

Pharmacology

Trimetazidine Dihydrochloride is the first 3- keto acyl CoA thiolase inhibitor (KAT), a metabolic anti-ischemic agent with proven benefits for all coronary patients. Trimetazidine Dihydrochloride inhibits fatty acid pathway by inhibiting 3-keto acyl CoA thiolase enzyme and transfers oxygen to glucose pathway. Since glucose pathway is more efficient in producing energy, the same oxygen produces more energy and makes the heart more active. Moreover, the aerobic oxidation of glucose stops production of lactic acid, which prevents angina pectoris.

Dosage & Administration

The recommended dose of Trimetazidine is 35 mg twice daily or 20 mg tablet thrice daily during meals. The benefit of the treatment should be assessed after three months and Trimetazidine should be discontinued if there is no treatment response.

Interaction

No drug interaction so far has been reported. In particular, no interaction has been reported with beta-blockers, calcium antagonists, nitrates, heparin, hypolipidemic agents or digitalis preparation.

Contraindications

Trimetazidine is contraindicated in patients who have hypersensitivity to the active substance or to any of the excipients. It is also is contraindicated in patients with Parkinson’s disease, parkinsonian symptoms, tremors, restless legs movement disorders, severe renal impairment.

Side Effects

Trimetazidine is safe and well tolerated. The Common side effects associated with Trimetazidine are dizziness, headache, abdominal pain, diarrhoea, dyspepsia, nausea, vomiting, rash, pruritus, urticaria and asthenia

Pregnancy & Lactation

There is no data on the use of Trimetazidine in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity. As a precautionary measure, it is preferable to avoid the use of Trimetazidine during pregnancy. It is unknown whether Trimetazidine is excreted in human milk. A risk to the newborns/infants cannot be excluded. Trimetazidine should not be used during breast-feeding.

Precautions & Warnings

Trimetazidine is not a curative treatment for angina attacks, nor an initial treatment for unstable angina pectoris. It is also not a treatment for myocardial infarction.

Storage Conditions

Keep in a dry place away from light and heat. Keep out of the reach of children.

Alternative brands of Trimetazidine Dihydrochloride

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.